Literature DB >> 28353186

A novel phenotypic assay of hepatitis B virus polymerase with extensive site-specific mutagenesis.

Ya Liu1, Ying-Ying Luo1, Xue-Fei Cai1, Quan-Xin Long1, Chun-Yang Gan1, Liu-Qing Yang1, Haitao Guo2, Ai-Long Huang1,3, Wen-Lu Zhang4, Jie-Li Hu5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28353186      PMCID： PMC6598925          DOI： 10.1007/s12250-016-3932-0

Source DB:  PubMed          Journal:  Virol Sin        ISSN： 1995-820X            Impact factor:   4.327


× No keyword cloud information.
  8 in total

1.  Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).

Authors:  K Das; X Xiong; H Yang; C E Westland; C S Gibbs; S G Sarafianos; E Arnold
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection.

Authors:  S K Ono-Nita; N Kato; Y Shiratori; T Masaki; K H Lan; F J Carrilho; M Omata
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

3.  Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment.

Authors:  Toshihiko Kirishima; Takeshi Okanoue; Yukiko Daimon; Yoshito Itoh; Hideki Nakamura; Atsuhiro Morita; Tetsuya Toyama; Masahito Minami
Journal:  J Hepatol       Date:  2002-08       Impact factor: 25.083

4.  Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy.

Authors:  K Chayama; Y Suzuki; M Kobayashi; M Kobayashi; A Tsubota; M Hashimoto; Y Miyano; H Koike; M Kobayashi; I Koida; Y Arase; S Saitoh; N Murashima; K Ikeda; H Kumada
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

5.  A novel method for nucleos(t)ide analogues susceptibility assay of hepatitis B virus by viral polymerase transcomplementation.

Authors:  Ying-ying Luo; Ying Tao; Xue-fei Cai; Wen-lu Zhang; Quan-xin Long; Haitao Guo; Ai-long Huang; Jie-li Hu
Journal:  Antiviral Res       Date:  2015-12-29       Impact factor: 5.970

Review 6.  Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations.

Authors:  Angeline Bartholomeusz; Benjamin G Tehan; David K Chalmers
Journal:  Antivir Ther       Date:  2004-04

7.  Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance.

Authors:  Carl J Baldick; Daniel J Tenney; Charles E Mazzucco; Betsy J Eggers; Ronald E Rose; Kevin A Pokornowski; Cheng F Yu; Richard J Colonno
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

8.  Targeting Hepatitis B Virus With CRISPR/Cas9.

Authors:  Christoph Seeger; Ji A Sohn
Journal:  Mol Ther Nucleic Acids       Date:  2014-12-16       Impact factor: 10.183
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.